BRD-K06240250-001-01-6
HELA
maintaining cell culture
L1000-Phase2
cervical adenocarcinoma
datapackage.zip
LINCS
L1000 LINCS DCIC REP.A011 HELA 24H H23 rilpivirine 0.12um.tsv.gz
uterine cervix
Label
Description
A Substance
A 123 KB file from LINCS produced from OBI:0002965 as part of the L1000 Phase2 project